CCND1 and neoplasm: As myeloid-derived suppressor cells (MDSCs) accumulate in tumors during malignant progression and in ex vivo CTL assays can suppress T cell responses [65] and block DC maturation at the invasive edge of tumors [65], the current studies suggest a novel mechanism by which stromal cyclin D1 may augment tumor progression.